Insider Activity of Poulton Stuart
According to the SEC Form 4 filings, Poulton Stuart, being in a position of
- EVP, Chief Development Officer at Karyopharm Therapeutics Inc.,оver the last 12 months, has bought 0 shares, and sold 31196 shares for $37,309,over all time since 2023-02-15, has bought 0 shares, and sold 39910 shares for $60,862.
The largest sale of all time was on 2024-02-29 and amounted to 16311 share of Karyopharm Therapeutics Inc. for $19,084.
Biography of Poulton Stuart
No biography is available at this moment.